OFI Invest Asset Management Has $9.79 Million Position in McKesson Corporation $MCK

Key Points

• OFI Invest Asset Management boosted its stake in McKesson by 1,019.5% in Q4 to 11,934 shares worth about $9.79 million, and institutional investors now own roughly 85.1% of the stock.
• Analysts are broadly positive: McKesson has 13 Buy vs 3 Hold ratings with an average target of $970.93 (market consensus "Moderate Buy"), and several firms (e.g., Barclays) have raised targets to as high as $1,050.
• Fundamentals show an EPS beat ($9.34 vs. $9.19) on $106.16B revenue and FY2026 guidance of $38.80–$39.20 EPS, while insiders recently sold about 3,592 shares (~$3.52M); the company pays a quarterly dividend of $0.82 (yield ~0.4%).

OFI Invest Asset Management boosted its holdings in shares of McKesson Corporation (NYSE:MCK - Free Report) by 1,019.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,934 shares of the company's stock after buying an additional 10,868 shares during the period. OFI Invest Asset Management's holdings in McKesson were worth $9,789,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in MCK. Brighton Jones LLC lifted its holdings in shares of McKesson by 46.3% during the fourth quarter. Brighton Jones LLC now owns 2,523 shares of the company's stock valued at $1,438,000 after acquiring an additional 798 shares during the period. Caxton Associates LLP bought a new position in shares of McKesson during the first quarter valued at $233,000. Sivia Capital Partners LLC lifted its holdings in shares of McKesson by 77.9% during the second quarter. Sivia Capital Partners LLC now owns 685 shares of the company's stock valued at $502,000 after acquiring an additional 300 shares during the period. Cresset Asset Management LLC lifted its holdings in shares of McKesson by 28.7% during the second quarter. Cresset Asset Management LLC now owns 1,176 shares of the company's stock valued at $863,000 after acquiring an additional 262 shares during the period. Finally, WINTON GROUP Ltd bought a new position in shares of McKesson during the second quarter valued at $1,329,000. 85.07% of the stock is owned by institutional investors.

Analyst Ratings Changes

MCK has been the subject of a number of analyst reports. Wells Fargo & Company lifted their price objective on McKesson from $914.00 to $925.00 and gave the company an "equal weight" rating in a report on Thursday, February 5th. Raymond James Financial set a $970.00 price objective on McKesson in a report on Thursday, March 5th. Wall Street Zen raised McKesson from a "hold" rating to a "buy" rating in a report on Sunday, March 22nd. Barclays lifted their price target on McKesson from $960.00 to $1,050.00 and gave the company an "overweight" rating in a report on Wednesday, February 18th. Finally, Evercore reaffirmed an "outperform" rating on shares of McKesson in a report on Thursday, March 5th. Thirteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $970.93.

Insider Transactions at McKesson

In other McKesson news, EVP Michele Lau sold 2,725 shares of the business's stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $990.00, for a total transaction of $2,697,750.00. Following the completion of the sale, the executive vice president directly owned 3,247 shares of the company's stock, valued at approximately $3,214,530. The trade was a 45.63% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Maria Martinez sold 349 shares of the business's stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $939.87, for a total value of $328,014.63. Following the sale, the director directly owned 301 shares of the company's stock, valued at $282,900.87. This represents a 53.69% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 3,592 shares of company stock valued at $3,518,555. 0.08% of the stock is owned by company insiders.

McKesson Stock Up 0.2%

McKesson stock opened at $873.15 on Friday. The stock has a 50-day simple moving average of $915.53 and a 200 day simple moving average of $849.29. McKesson Corporation has a 12-month low of $637.00 and a 12-month high of $999.00. The stock has a market capitalization of $106.95 billion, a price-to-earnings ratio of 25.11, a P/E/G ratio of 1.27 and a beta of 0.42.

McKesson (NYSE:MCK - Get Free Report) last released its quarterly earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $9.19 by $0.15. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The business had revenue of $106.16 billion during the quarter, compared to analysts' expectations of $105.98 billion. During the same period in the previous year, the business posted $8.03 earnings per share. The firm's revenue for the quarter was up 11.4% compared to the same quarter last year. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. As a group, sell-side analysts anticipate that McKesson Corporation will post 32.77 EPS for the current year.

McKesson Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, April 1st. Shareholders of record on Monday, March 2nd were issued a dividend of $0.82 per share. This represents a $3.28 annualized dividend and a yield of 0.4%. The ex-dividend date of this dividend was Monday, March 2nd. McKesson's payout ratio is currently 9.43%.

About McKesson

McKesson Corporation NYSE: MCK is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company's core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.